Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2026-05-12 @ 3:48 PM
Study NCT ID:
NCT05110157
Status:
COMPLETED
Last Update Posted:
2025-07-10
First Post:
2021-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Sponsor:
Neurocrine Biosciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Schizophrenia | View |